Document is current
Any future updates will be listed below
-
Authors
El Nahhas, Omar S. M. https://orcid.org/0000-0002-2542-2117
van Treeck, Marko
Wölflein, Georg https://orcid.org/0000-0002-0407-7617
Unger, Michaela
Ligero, Marta
Lenz, Tim
Wagner, Sophia J.
Hewitt, Katherine J.
Khader, Firas
Foersch, Sebastian
Truhn, Daniel
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
- License Information
-
More Information
Article History
Received: 17 December 2023
Accepted: 4 July 2024
First Online: 16 September 2024
Competing interests
: O.S.M.E.N., F.K. and D.T. hold shares in StratifAI GmbH. J.N.K. declares consulting services for Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK,; Scailyte, Switzerland; Mindpeak, Germany; and Histofy, UK; furthermore, he holds shares in StratifAI GmbH, Germany, and has received honoraria for lectures by AstraZeneca, Bayer, Eisai, MSD, BMS, Roche, Pfizer and Fresenius. D.T. received honoraria for lectures by Bayer and holds shares in StratifAI GmbH, Germany. S.F. has received honoraria from MSD and BMS.
